(HealthDay)—For patients with advanced squamous non-small cell lung cancer (sq- NSCLC), adding tislelizumab in combination with chemotherapy is associated with improved progression-free survival (PFS), according to […]
(HealthDay)—From 2005 to 2015, there was an increase in prolonged length of stay (LOS) for pediatric mental health emergency department visits, according to a study published […]
(HealthDay)—Annual medical costs associated with substance use disorder (SUD) in U.S. emergency departments and inpatient settings exceeded $13 billion in 2017, according to a study published […]